Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

Targeting Alopecia with Plant Power

| Saad Harti | 8 min read

A drug development story: how one company filed a marketing authorization in Europe for a botanical drug to treat alopecia areata.

Discovery & Development Drug Discovery

Neural Networks Vs Bruteforce Docking

| Ina Pöhner | 4 min read

How Finnish researchers carried out one of the world's largest virtual drug screens using AI

Discovery & Development Drug Delivery

The Viral Frontier

| Fatima Mohsin | 4 min read

How virus-based cancer therapeutic strategies could increase treatment efficacy

Discovery & Development Drug Discovery

AI: Hype or High Performance?

| Michael Parker | 4 min read

Generative chemistry and other exciting applications of artificial intelligence in small molecule drug discovery

Discovery & Development Drug Discovery

T Cells, Sea Shells and Cancer Cures

| 5 min read

Adrian Baez-Ortega shares on pioneering the genome sequencing of transmissible cancers in cockles – and what this research means for humans.

Business & Regulation Standards & Regulation

Another Year of Innovation

| Stephanie Vine

A video tour of the top FDA approvals from 2023

Discovery & Development Drug Discovery

Pharma’s Portal to the Lab of the Future

| Becky Upton | 4 min read

Labs of the future will use VR, AR, AI and more. But we must overcome the barriers of implementation, including cultural resistance.

Discovery & Development Drug Discovery

Release the Beast

| Pandora Pound | 5 min read

The FDA Modernization Act opens the door for more innovative alternatives to animal testing for drug discovery and development

Discovery & Development Drug Discovery

Addressing Epilepsy

| Stefanie Dedeurwaerdere | 4 min read

The challenges of complex disorders require collaboration, embracing technological developments, and acknowledging the gaps in access to medicine

Discovery & Development Drug Delivery

At First Sight

| Jamie Irvine | 13 min read

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register